Cargando…
ASSOCIATION OF NEW ONSET ATRIAL FIBRILLATION WITH ALL-CAUSE MORTALITY IN COVID 19 PATIENTS.
Autores principales: | Mansoor, Kanaan, Rabbani, Noor Ul Ann, Rahman, Ebad Ur, Assad, Salman, Ahmed, Huma Nadeem, Gress, Todd, Fonarow, Gregg C., El-Hamdani, Mehiar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Cardiology Foundation. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972575/ http://dx.doi.org/10.1016/S0735-1097(22)01098-1 |
Ejemplares similares
-
VACCINE ASSOCIATED ATRIAL FIBRILLATION
por: Ghoweba, Mohamed, et al.
Publicado: (2022) -
Bi‐atrial characterization of the electrical substrate in patients with atrial fibrillation
por: Giorgios, Tsitsinakis, et al.
Publicado: (2022) -
Impact of left atrial box surface ratio on the recurrence after ablation for persistent atrial fibrillation
por: Keçe, Fehmi, et al.
Publicado: (2019) -
PROGNOSTIC SIGNIFICANCE OF NEW-ONSET ATRIAL FIBRILLATION IN COVID-19
por: Ko, Darae, et al.
Publicado: (2022) -
Identification of Left Atrial Ganglionated Plexi by Dense Epicardial Mapping as Ablation Targets for the Treatment of Concomitant Atrial Fibrillation
por: Kondo, Yusuke, et al.
Publicado: (2013)